PDL BioPharma, Inc. Restricted Stock Agreement Amendment Acknowledgment
Contract Categories:
Business Finance
›
Equity Distribution Agreements
Summary
This agreement acknowledges that PDL BioPharma, Inc. has amended its Restricted Stock Agreement as of November 15, 2019, under its Equity Incentive Plan. The participant agrees to the updated terms, which now govern their restricted stock awards as detailed in the attached grant notice(s). The document also references the 2018 Amended Restated 2005 Equity Incentive Plan. Both the company and the participant must sign to confirm acceptance of the amended agreement.
EX-10.69 6 pdli1231201910-kex1069.htm FORM OF RESTRICTED STOCK AGREEMENT AMENDMENT ACKNOWLEDGEMENT Exhibit
Exhibit 10.69
PDL BioPharma, Inc.
Restricted Stock Agreement Amendment Acknowledgment
The Board of PDL BioPharma, Inc., has on November 15, 2019, amended the Restricted Stock Agreement applicable to the attached Restricted Stock Grant Notice(s) pursuant to Section 3(b)(viii) of the Equity Incentive Plan, with the intent that such amended Restricted Stock Agreement shall be applicable thereto. The Participant acknowledges, agrees and accepts the amended Restricted Stock Agreement as governing the awards represented in the attached Notice(s):
Notice(s) of Grant of Restricted Stock Award of [ ].
In addition, attached is the 2018 Amended Restated 2005 Equity Incentive Plan “plan” and Assignment.
PDL BIOPHARMA, INC. | PARTICIPANT | |||
By: | By: | |||
Print Name: | Print Name: | |||
Title: | ||||
Date: | Date: | |||
